Graham Lock
GlaxoSmithKline
This will be a discussion of some of the real issues that arise in the registration of chemical structures within the pharmaceutical industry and how GSK have worked with Modgraph to solve them. These are matters that are too often overlooked when initially designing systems but will always come back to haunt the unwary